Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
Alain Fischer(Inserm), Lionel Galicier(Hôpital de la Timone), Bernard Bonnotte(Université de Bourgogne), P. Arlet(Centre de Référence Déficits Immunitaires Héréditaires), Olivia Chandesris, I. Durieu, Claire Fieschi(Délégation Paris 7), Anne Deville, Nathalie Aladjidi, Jean Donadieu(Sorbonne Université), Damien Bodet, Catherine Devoldère, Alexandre Alcaïs(Inserm), Johan Provot(Centre de Référence Déficits Immunitaires Héréditaires), Elodie Curlier, D. Adoué, Brigitte Bader‐Meunier(Hôpital Necker-Enfants Malades), Geneviève de Saint Basile(Inserm), Vincent Barlogis, Patrick Boutard, Claire Briandet, Virginie Courteille, Stéphane Blanche(Hôpital Necker-Enfants Malades), Fanny Fouyssac(Unknown), Hélène Coignard-Biehler, Nizar Mahlaoui(Hôpital Necker-Enfants Malades), Boris Bienvenu(Hôpital Saint Joseph), Pierre Frange(Hôpital Necker-Enfants Malades), Corinne Armari‐Alla, Carolina Brito(Universidade Federal do Rio Grande do Sul), Raphaël Borie(Inserm), Gérard Couillault, Jean‐Philippe Jaïs(Délégation Paris 5), C. Edan, Jean‐Paul Brion, Émilie Catherinot, Yves Bertrand(Hôpital Debrousse), Zahir Amoura, François Deméocq, Vincent Gajdos, Laurence Costes(Université de Bordeaux), Louis‐Jean Couderc, Jacques Brouard, Éric Doré, Sophie Bayart, Beatrice Beaurain, Nathalie de Vergnes, Natacha Entz Werle
Cited by 316
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k